Literature DB >> 21852699

Indirect comparison of two quantitative immunochemical faecal occult blood tests in a population with average colorectal cancer risk.

L Guittet1, L Bailly, V Bouvier, G Launoy.   

Abstract

Magstream and OC Sensor quantitative immunochemical faecal occult blood tests (IFOBT) have shown better performances than guaiac (G) tests in colorectal cancer screening, however Magstream and OC Sensor have never been compared. We hypothesized that similar performances could be observed with Magstream and OC Sensors, provided a similar cut-off (expressed in concentration of haemoglobin in the stools) is used. We performed a literature-based indirect comparison between these tests, taking into account the cut-off, the number of samples, and the way they were combined (I(2+): at least one positive sample of 2; I(2++): both positive samples; I(1): only one sample). Six studies conducted in general average-risk populations were included in this review. For each [test]*[cut-off], positivity rate (PR) decreased and predictive positive value (PPV) increased from I(2+) to I(1) and I(2++.) For similar PR, PPV with OC Sensor was greater than with Magstream. This could be due to factors other than the test, because PPVs associated with GFOBT in studies evaluating OC Sensor were greater than PPVs associated with GFOBT in the study evaluating Magstream. Direct comparison between Magstream and OC Sensor is needed to confirm the suspected superiority of OC Sensor.

Entities:  

Mesh:

Year:  2011        PMID: 21852699     DOI: 10.1258/jms.2011.011012

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  1 in total

1.  Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Authors:  Gemma Binefa; Montse Garcia; Núria Milà; Esteve Fernández; Francisco Rodríguez-Moranta; Núria Gonzalo; Llúcia Benito; Ana Clopés; Jordi Guardiola; Víctor Moreno
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.